Clinical Trial Update: Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating volume substitution and insulin therapy for severe sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Insulin (insulin)
• Normal Saline (sodium chloride 0.9% solution)

Snippet

Sponsor: SepNet - Critical Care Trials Group | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: COMPLETED